欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/1786/001
药品名称
Ridracid
活性成分
risedronate sodium salt 35.0 mg
剂型
Film-coated tablet
上市许可持有人
ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
参考成员国 - 产品名称
Denmark (DK)
42403
互认成员国 - 产品名称
许可日期
2010/06/03
最近更新日期
2018/10/18
药物ATC编码
M05BA07 risedronic acid
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
Risedronat_DK_H_1786_OuP_2BImP_25_06_18
Date of last change:2024/09/06
Final PL
|
Risedronat_PIL_DCP_1274_1275_1785_1786_EN_22_12_15
Date of last change:2024/09/06
Final SPC
|
Risedronat_SmPC_DCP_1274_1275_1785_1786_EN_30_10_15
Date of last change:2024/09/06
市场状态
Withdrawn(注:已撤市)
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase